IQVIA supports sites and participants through patient-centric trial experiences

VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, announced that InMed’s Chief Executive Officer, Eric A. Adam’s will present a company overview at the H.C. Wainwright 25th Annual Global Investment Conference which takes place Se